Imatinib Mesylate in Treating Patients With Stage IV Colorectal Cancer

Summary

Phase II trial to study the effectiveness of imatinib mesylate in treating patients who have stage IV colorectal cancer. Imatinib mesylate may interfere with the growth of tumor cells by blocking certain enzymes necessary for cancer cell growth

Timeline

Start

2002-05

Primary completion

2006-07

Completion

—

Drugs

Indications